HLN
Price
$9.71
Change
-$0.10 (-1.02%)
Updated
Aug 25, 11:27 AM (EDT)
Capitalization
44.17B
66 days until earnings call
TAK
Price
$15.10
Change
-$0.42 (-2.71%)
Updated
Aug 25, 04:22 PM (EDT)
Capitalization
49.18B
66 days until earnings call
Interact to see
Advertisement

HLN vs TAK

Header iconHLN vs TAK Comparison
Open Charts HLN vs TAKBanner chart's image
Haleon
Price$9.71
Change-$0.10 (-1.02%)
Volume$305
Capitalization44.17B
Takeda Pharmaceutical
Price$15.10
Change-$0.42 (-2.71%)
Volume$12.61K
Capitalization49.18B
HLN vs TAK Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. TAK commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Buy and TAK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (HLN: $9.82 vs. TAK: $15.52)
Brand notoriety: HLN and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 115% vs. TAK: 91%
Market capitalization -- HLN: $44.17B vs. TAK: $49.18B
HLN [@Pharmaceuticals: Generic] is valued at $44.17B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $49.18B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $69.41B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 3 bearish.
  • TAK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HLN is a better buy in the short-term than TAK.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а +1.76% price change this week, while TAK (@Pharmaceuticals: Generic) price change was +3.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.61%. For the same industry, the average monthly price growth was +9.48%, and the average quarterly price growth was +70.32%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($49.2B) has a higher market cap than HLN($44.2B). TAK has higher P/E ratio than HLN: TAK (53.48) vs HLN (21.91). TAK YTD gains are higher at: 17.221 vs. HLN (4.745). TAK has higher annual earnings (EBITDA): 1.13T vs. HLN (2.71B). TAK has more cash in the bank: 419B vs. HLN (676M). HLN has less debt than TAK: HLN (8.45B) vs TAK (4.51T). TAK has higher revenues than HLN: TAK (4.48T) vs HLN (11B).
HLNTAKHLN / TAK
Capitalization44.2B49.2B90%
EBITDA2.71B1.13T0%
Gain YTD4.74517.22128%
P/E Ratio21.9153.4841%
Revenue11B4.48T0%
Total Cash676M419B0%
Total Debt8.45B4.51T0%
FUNDAMENTALS RATINGS
TAK: Fundamental Ratings
TAK
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNTAK
RSI
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
39%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
47%
Momentum
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
41%
MACD
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
36%
Advances
ODDS (%)
Bullish Trend 6 days ago
57%
Bullish Trend 6 days ago
41%
Declines
ODDS (%)
Bearish Trend 20 days ago
52%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
41%
Aroon
ODDS (%)
Bearish Trend 4 days ago
27%
Bearish Trend 4 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SNOV24.240.56
+2.36%
FT Vest U.S. Sm Cp Mod Buf ETF -Nov
VNQI47.860.71
+1.51%
Vanguard Global ex-US Real Est ETF
XTJA30.300.25
+0.84%
Innovator US Equity Acclrtd Pls ETF Jan
MYCG25.050.05
+0.20%
SPDR SSGA My2027 Corporate Bond ETF
DFCA49.250.04
+0.08%
Dimensional California Municipal Bd ETF

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+0.10%
HLNCF - HLN
49%
Loosely correlated
+0.31%
TAK - HLN
42%
Loosely correlated
+1.37%
ZTS - HLN
40%
Loosely correlated
+0.65%
ALKS - HLN
29%
Poorly correlated
+2.37%
PRGO - HLN
29%
Poorly correlated
+4.52%
More